Access cutting-edge gastric cancer treatment through this clinical trial at a research site in La Jolla. Study-provided care at no cost to qualified participants.
Access gastric cancer specialists in La Jolla at no cost
This study follows strict safety protocols and ethical guidelines
All study-related gastric cancer treatment provided free
This is a Phase Ⅲ, randomized, open-label, Sponsor-blinded, 3-arm, global, multicenter study assessing the efficacy and safety of rilvegostomig in combination with fluoropyrimidine and T-DXd (Arm A) compared to trastuzumab, chemotherapy, and pembrolizumab (Arm B) in HER2-positive locally advanced or metastatic gastric or GEJ adenocarcinoma participants whose tumors express PD L1 CPS ≥ 1. Rilvegostomig in combination with trastuzumab and chemotherapy will be evaluated in a separate arm (Arm C) to
Sponsor: AstraZeneca
Check if you qualify for this gastric cancer clinical trial in La Jolla, CA
If you're searching for gastric cancer treatment options in La Jolla, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our La Jolla research site is actively enrolling participants for this clinical trial. You'll receive care from experienced gastric cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.